meglumine and Aging
meglumine has been researched along with Aging in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors
Authors | Studies |
---|---|
Baltzer, PAT; Burke, CJ; Hellmich, M; Krug, KB; Maintz, D; Rhiem, K; Schlamann, M; Weiss, K | 1 |
Bashir, MR; Breault, SR; Dale, BM; Faridi, KF; Gupta, RT; Heye, T; Merkle, EM; Reiner, CS | 1 |
Kirchin, MA; Lorusso, V; Patel, R; Pirovano, G; Shen, N | 1 |
Aquino, D; Barral, A; Barral-Netto, M; Caldas, AJ; Costa, J; Silva, AA | 1 |
Claussen, CD; Dietz, K; Müller-Schimpfle, M; Ohmenhaüser, K; Stoll, P | 1 |
Mienville, JM; Pesold, C | 1 |
Mody, I; Otis, TS | 1 |
Trials
1 trial(s) available for meglumine and Aging
Article | Year |
---|---|
Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?
Topics: Adolescent; Adult; Aging; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2006 |
Other Studies
6 other study(ies) available for meglumine and Aging
Article | Year |
---|---|
Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
Topics: Aging; Brain; Breast Neoplasms; Case-Control Studies; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Retrospective Studies | 2022 |
Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Bone Marrow; Contrast Media; Female; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Meglumine; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Organometallic Compounds; Pelvic Bones; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Young Adult | 2013 |
Pharmacokinetics of gadobenate dimeglumine in children 2 to 5 years of age undergoing MRI of the central nervous system.
Topics: Aging; Brain; Child, Preschool; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Metabolic Clearance Rate; Organometallic Compounds | 2015 |
Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.
Topics: Adolescent; Adult; Aged; Aging; Breast; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Menstrual Cycle; Middle Aged; Organometallic Compounds; Pentetic Acid | 1997 |
Low resting potential and postnatal upregulation of NMDA receptors may cause Cajal-Retzius cell death.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Adenosine Triphosphate; Aging; Animals; Cell Death; Cerebral Cortex; Dizocilpine Maleate; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Immunohistochemistry; In Vitro Techniques; Meglumine; Membrane Potentials; N-Methylaspartate; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Piperazines; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate; Tetrodotoxin; Up-Regulation | 1999 |
Modulation of decay kinetics and frequency of GABAA receptor-mediated spontaneous inhibitory postsynaptic currents in hippocampal neurons.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Aging; Anesthetics, Local; Animals; Calcium Channels; Evoked Potentials; Flumazenil; Hippocampus; Kinetics; Lidocaine; Mathematics; Meglumine; Membrane Potentials; Midazolam; Models, Neurological; Neurons; Pentobarbital; Probability; Quinoxalines; Rats; Rats, Wistar; Receptors, GABA-A; Synapses; Tetrodotoxin | 1992 |